News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,737 Results
Type
Article (58249)
Company Profile (237)
Press Release (628236)
Multimedia
Podcasts (149)
Webinars (23)
Section
Business (191981)
Career Advice (2697)
Deals (34636)
Drug Delivery (136)
Drug Development (79859)
Employer Resources (194)
FDA (16730)
Job Trends (14016)
News (331870)
Policy (33893)
Tag
Academia (2538)
Academic (1)
Accelerated approval (27)
Adcomms (35)
Allergies (126)
Alliances (44734)
ALS (161)
Alzheimer's disease (1721)
Antibody-drug conjugate (ADC) (297)
Approvals (16830)
Artificial intelligence (494)
Autoimmune disease (132)
Automation (29)
Bankruptcy (356)
Best Places to Work (10539)
BIOSECURE Act (23)
Biosimilars (182)
Biotechnology (173)
Bladder cancer (151)
Brain cancer (59)
Breast cancer (592)
Cancer (4488)
Cardiovascular disease (391)
Career advice (2273)
Career pathing (39)
CAR-T (282)
CDC (59)
Cell therapy (741)
Cervical cancer (34)
Clinical research (67608)
Collaboration (1492)
Company closure (4)
Compensation (1075)
Complete response letters (65)
COVID-19 (2876)
CRISPR (88)
C-suite (711)
Cystic fibrosis (141)
Data (5676)
Decentralized trials (2)
Denatured (39)
Depression (129)
Diabetes (468)
Diagnostics (6244)
Digital health (33)
Diversity (8)
Diversity, equity & inclusion (49)
Drug discovery (231)
Drug pricing (200)
Drug shortages (33)
Duchenne muscular dystrophy (223)
Earnings (87930)
Editorial (60)
Employer branding (24)
Employer resources (166)
Events (101124)
Executive appointments (942)
FDA (19519)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1292)
Gene editing (193)
Generative AI (44)
Gene therapy (600)
GLP-1 (1061)
Government (4778)
Grass and pollen (8)
Guidances (378)
Healthcare (17049)
HIV (52)
Huntington's disease (45)
IgA nephropathy (78)
Immunology and inflammation (274)
Immuno-oncology (40)
Indications (72)
Infectious disease (3134)
Inflammatory bowel disease (190)
Inflation Reduction Act (14)
Influenza (108)
Intellectual property (213)
Interviews (495)
IPO (16916)
IRA (56)
Job creations (3802)
Job search strategy (1885)
Kidney cancer (16)
Labor market (87)
Layoffs (636)
Leadership (38)
Legal (8094)
Liver cancer (90)
Longevity (13)
Lung cancer (609)
Lymphoma (347)
Machine learning (38)
Management (62)
Manufacturing (707)
MASH (162)
Medical device (12649)
Medtech (12682)
Mergers & acquisitions (18700)
Metabolic disorders (1253)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (299)
Neuropsychiatric disorders (82)
Neuroscience (2867)
NextGen: Class of 2025 (5771)
Non-profit (3679)
Now hiring (62)
Obesity (614)
Opinion (310)
Ovarian cancer (149)
Pain (186)
Pancreatic cancer (201)
Parkinson's disease (262)
Partnered (31)
Patents (456)
Patient recruitment (402)
Peanut (56)
People (53849)
Pharmaceutical (47)
Pharmacy benefit managers (29)
Phase I (20802)
Phase II (29589)
Phase III (22861)
Pipeline (3871)
Policy (311)
Postmarket research (2608)
Preclinical (8677)
Press Release (66)
Prostate cancer (222)
Psychedelics (52)
Radiopharmaceuticals (270)
Rare diseases (782)
Real estate (5433)
Recruiting (76)
Regulatory (25105)
Reports (65)
Research institute (2341)
Resumes & cover letters (434)
Rett syndrome (24)
RNA editing (16)
RSV (73)
Schizophrenia (141)
Series A (224)
Series B (171)
Service/supplier (12)
Sickle cell disease (95)
Special edition (26)
Spinal muscular atrophy (159)
Sponsored (45)
Startups (3466)
State (1)
Stomach cancer (19)
Supply chain (99)
Tariffs (97)
The Weekly (109)
Vaccines (1087)
Venture capital (80)
Weight loss (431)
Women's health (66)
Worklife (21)
Date
Today (86)
Last 7 days (549)
Last 30 days (2377)
Last 365 days (30892)
2025 (30428)
2024 (34917)
2023 (39433)
2022 (50550)
2021 (54440)
2020 (51590)
2019 (42406)
2018 (32205)
2017 (33015)
2016 (31720)
2015 (35933)
2014 (30778)
2013 (26559)
2012 (26455)
2011 (26972)
2010 (25131)
Location
Africa (864)
Alabama (75)
Alaska (6)
Arizona (247)
Arkansas (12)
Asia (41178)
Australia (6970)
California (10282)
Canada (2816)
China (967)
Colorado (404)
Connecticut (463)
Delaware (315)
Europe (96407)
Florida (1528)
Georgia (310)
Hawaii (3)
Idaho (56)
Illinois (746)
India (51)
Indiana (485)
Iowa (20)
Japan (373)
Kansas (116)
Kentucky (27)
Louisiana (23)
Maine (74)
Maryland (1329)
Massachusetts (7530)
Michigan (291)
Minnesota (587)
Mississippi (5)
Missouri (116)
Montana (23)
Nebraska (22)
Nevada (111)
New Hampshire (72)
New Jersey (2812)
New Mexico (22)
New York (2727)
North Carolina (1369)
North Dakota (9)
Northern California (4927)
Ohio (289)
Oklahoma (17)
Oregon (37)
Pennsylvania (2060)
Puerto Rico (14)
Rhode Island (35)
South America (1212)
South Carolina (58)
South Dakota (1)
Southern California (4004)
Tennessee (150)
Texas (1567)
United States (36726)
Utah (290)
Virginia (236)
Washington D.C. (73)
Washington State (837)
West Virginia (4)
Wisconsin (98)
Wyoming (2)
686,737 Results for "wong s biotech stock report".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
Uptick in Dealmaking, Chinese Partnerships Drive Biotech’s Comeback
Biotech’s slump may finally be over in 2026. In interviews with
BioSpace
, Zymeworks’ CEO Ken Galbraith and Zai Lab’s President and COO Josh Smiley explain what’s fueling the comeback.
December 17, 2025
·
3 min read
·
Jennifer Smith-Parker
Obesity
Structure Stock Soars as Oral GLP-1 Generates ‘Highly Competitive’ Weight Loss
Structure’s aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech’s stock up nearly 103% as markets closed on Monday.
December 9, 2025
·
2 min read
·
Tristan Manalac
Regulatory
6 Biotechs With a Shot at the FDA’s Platform Technology Designation
After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the regulator’s radar.
November 21, 2025
·
9 min read
·
Tristan Manalac
Insights
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year of transformation and renewed momentum for life sciences.
November 12, 2025
·
5 min read
·
Jennifer Smith-Parker
Press Releases
Edesa Biotech Reports Fiscal Year 2025 Results
December 15, 2025
·
8 min read
Special edition
Deep Dive: Chinese Biotech Innovation Can’t Be Stopped
In this deep dive,
BioSpace
investigates China’s rise as a biotech powerhouse.
October 27, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
November 17, 2025
·
12 min read
IPO
SPACs Line Up To Clear Biotech’s IPO Backlog
Blank check deals dwindled after a crazy 2021. Now, biotechs are starting to turn to special purpose acquisition companies again as an easy route to the public markets.
September 3, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 17, 2025
·
16 min read
FDA
Krystal Biotech’s FDA Platform Designation Pushes Limits of the Award
The company’s technology, a modified herpes simplex virus used to deliver gene therapies, was given the FDA’s new designation based on its approved topical skin cream. What this will mean for Krystal’s still-in-development eye drop is unclear.
October 21, 2025
·
2 min read
·
Dan Samorodnitsky
1 of 68,674
Next
